Q2 2026 Holdings
Filed 2026-08-14 | 6 holdings | $290.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Pharvaris N.V.(PHVS) | COM | N69605108 | $165.2M | 4,778,581 | 57.0% |
| Cytokinetics Inc(CYTK) | COM | 23282W605 | $60.9M | 714,695 | 21.0% |
| Eikon Therapeutics, Inc.(EIKN) | COM | 282564103 | $25.4M | 1,943,682 | 8.7% |
| Relay Therapeutics, Inc.(RLAY) | COM | 75943R102 | $23.4M | 1,250,000 | 8.1% |
| Xenon Pharmaceuticals Inc.(XENE) | COM | 98420N105 | $9.7M | 160,000 | 3.3% |
| Crinetics Pharmaceuticals, Inc.(CRNX) | COM | 22663K107 | $5.6M | 150,000 | 1.9% |